See also this year's filing and all EDGAR filings for this company.
PDF Report 0001426332_2024_NGM_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
Graph
Absolute values for 0001426332, NGM Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 156,444,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,033,000 |
| 3 | remainder_Assets | 5,391,000 |
| 4 | LiabilitiesCurrent | 20,081,000 |
| 5 | LiabilitiesNoncurrent | 149,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,111,305 |
| 9 | ResearchAndDevelopmentExpense | 104,952,696 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 5,108,346 |
| 12 | remainder_NetIncome | 8,261,751 |
| 13 | remainder_ComprehensiveNetIncome | 187,972 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 168,868,000 |
| 1 | Liabilities | 20,230,000 |
| 2 | Expenses | 142,064,001 |
| 3 | Revenues | 5,108,346 |
| 4 | StockholdersEquity | 148,638,000 |
| 5 | NetIncome | -128,693,904 |
| 6 | ComprehensiveNetIncome | -128,599,918 |
| 7 | BaseVar | 172,360,035 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.07 |
| 9 | EconomicCapitalRatio | 3.07 |
Edgar->Model Mapping
Feature Distribution
Change over Time
